Barely Significant
← all excerpts

Redo-Transcatheter Aortic Valve Replacement: Strategies When the First Transcatheter Aortic Valve Replacement Fails.

US Cardiol · 2022 · PMC11588181 · PMID 39600834

1
hedged sentence
closest p
boldest claim

The sentences

a numerical trendno p-value reported
Interestingly, in another study, there was a numerical trend towards a higher 30-day mortality among patients who underwent redo-TAVR for procedural versus THV failure, but this was not statistically significant (5.4% versus 1.4%, respectively; p=0.427).[ 8 ] Periprocedural complications were low, and the 30-day survival was 94.6% in those undergoing redo-TAVR for procedural failure and 98.5% in those with THV failure (p=0.101).

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.